Acumen Pharmaceuticals Inc

General ticker "ABOS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $128.3M

Acumen Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -19.7%.

Estimated limits based on current volatility of 3.5%: low 1.74$, high 1.86$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.73$, 4.31$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.71$, 4.13$]

Financial Metrics affecting the ABOS estimates:

  • Negative: Non-GAAP EPS, $ of -1.09 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -23.86 <= 2.35
  • Positive: Interest expense per share, $ of 0 <= 0
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term ABOS quotes

Long-term ABOS plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $19.58MM $45.24MM $61.14MM
Operating Income $-19.58MM $-45.24MM $-61.14MM
Non-Operating Income $-81.02MM $2.38MM $8.77MM
R&D Expense $12.30MM $32.36MM $42.32MM
Income(Loss) $-100.61MM $-42.86MM $-52.37MM
Profit(Loss) $-100.61MM $-42.86MM $-52.37MM
Stockholders Equity $225.18MM $188.78MM $266.97MM
Assets $230.33MM $196.59MM $310.12MM
Operating Cash Flow $-17.96MM $-35.15MM $-43.06MM
Capital expenditure $0.04MM $0.16MM $0.02MM
Investing Cash Flow $-104.12MM $39.19MM $-171.67MM
Financing Cash Flow $200.47MM $3.91MM $151.75MM
Earnings Per Share* $-4.49 $-1.00 $-1.08

* EPS are Split Adjusted, recent splits may be reflected with a delay.